15
Apr

Uniondale, NY’s Angion Biomedica is eyeing $36 million to bankroll its pipeline of treatments for organ injury, hoping to buck an alarming trend for biotech stocks and trade on the Nasdaq under “ANGN.”

…read more

Source: Angion swings for a $36M IPO as biotech’s bear turn drags on

    

0 No comments